Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck submits NDA for new 2-in-1 hepatitis C treatment
Merck submits NDA for new 2-in-1 hepatitis C treatment
Merck submits NDA for new 2-in-1 hepatitis C treatment
Submitted by
admin
on May 29, 2015 - 10:44am
Source:
BioPharma Dive
News Tags:
Merck
hepatitis C
grazoprevir/elbagavir
grazoprevir
elbagavir
Headline:
Merck submits NDA for new 2-in-1 hepatitis C treatment
Do Not Allow Advertisers to Use My Personal information
